Surgeon variation affects QoL after prostatectomy

May 15, 2013
Surgeon variation affects QoL after prostatectomy
There is a significant association between performing surgeons and patient quality of life following radical prostatectomy, according to a study published in the April issue of The Journal of Urology.

(HealthDay)—There is a significant association between performing surgeons and patient quality of life following radical prostatectomy, according to a study published in the April issue of The Journal of Urology.

To examine the correlation between the surgeon performing prostatectomy and patient quality-of-life outcomes, Arthur Hartz, M.D., Ph.D., from the University of Utah in Salt Lake City, and colleagues surveyed 1,500 randomly selected patients from the Utah Cancer Registry who had had a prostatectomy for cancer cure more than one year previously, were 70 years of age or less, and had no metastatic disease or other .

The researchers found that the survey response rate was 64 percent. Twenty-two percent of the 678 responders reported leaking urine more than once per day. Seven percent used more than one pad per day and 40 percent reported that medication was necessary for an erection. Surgeon variation was significantly associated with erectile strength, urine leakage, and length of hospital stay. There was a significant correlation between surgeon risk-adjusted erectile outcomes and leakage outcomes and length of stay. There was also a significant correlation between annual surgeon volume and less leakage and shorter length of stay. Robotic surgery was associated with a shorter stay, compared with open retropubic surgery. Shorter stay, less , and weaker erection were associated with the perineal approach.

"We found that patient quality of life depends on the surgeon who performs the prostatectomy," the authors write. "A collaboration of clinicians working with a cancer registry might provide information useful for quality improvement."

Several authors disclosed to the pharmaceutical industry.

Explore further: Study confirms difference in radical prostatectomy outcomes between surgeons

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Study confirms difference in radical prostatectomy outcomes between surgeons

March 18, 2013
New evidence from Sweden confirms previous studies which suggest that functional outcomes after radical prostatectomy may vary between surgeons, especially in relation to continence. However, the group found no evidence of ...

Hospital stays shorter for prostatectomy, cystectomy

January 10, 2013
(HealthDay)—There were reductions in hospital stays for patients undergoing prostatectomy and cystectomy in 2004 to 2005, compared to those undergoing the procedures in 1992 to 1993, according to research published in the ...

Hospital surgical volume should be considered when judging value of procedures

May 5, 2013
The volume of cases performed at an institution each year has a direct effect on the outcome of surgical procedures, and should always be considered when looking at the benefits of a technique, according to a team of researchers ...

Similar outcomes for robotic, laparoscopic prostatectomy

April 17, 2013
(HealthDay)—For men undergoing routine surgical treatment for localized cancer of the prostate, robot-assisted radical prostatectomy (RALP) does not result in better functional outcomes compared to laparoscopic radical ...

Higher acute aortic dissection risk with lower-volume care

May 13, 2013
(HealthDay)—The mortality risk from emergency repair of acute aortic dissection is double when performed by lower-volume providers, according to research published in the May issue of the Annals of Thoracic Surgery.

Recommended for you

Researchers develop a remote-controlled cancer immunotherapy system

January 15, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

Pancreatic tumors may require a one-two-three punch

January 15, 2018
One of the many difficult things about pancreatic cancer is that tumors are resistant to most treatments because of their unique density and cell composition. However, in a new Wilmot Cancer Institute study, scientists discovered ...

New immunotherapy approach boosts body's ability to destroy cancer cells

January 12, 2018
Few cancer treatments are generating more excitement these days than immunotherapy—drugs based on the principle that the immune system can be harnessed to detect and kill cancer cells, much in the same way that it goes ...

Cancer's gene-determined 'immune landscape' dictates progression of prostate tumors

January 12, 2018
The field of immunotherapy - the harnessing of patients' own immune systems to fend off cancer - is revolutionizing cancer treatment today. However, clinical trials often show marked improvements in only small subsets of ...

FDA approves first drug for tumors tied to breast cancer genes

January 12, 2018
(HealthDay)—The U.S. Food and Drug Administration on Friday approved the first drug aimed at treating metastatic breast cancers linked to the BRCA gene mutation.

Breast cancer gene does not boost risk of death: study

January 12, 2018
Young women with the BRCA gene mutation that prompted actress Angelina Jolie's pre-emptive and much-publicised double mastectomy are not more likely to die after a breast cancer diagnosis, scientists said Friday.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.